Saturday, December 16, 2017

Skolkovo Fund to host international biomedical conference in Russia

The Skolkovo Fund recently announced that it will be holding the first-ever international biomedical conference in Russia from May 26-28 at its Hypercube facility.

Leading the project are Phillip Sharp, a 2003 Nobel Prize winner in physiology from the U.S., and Shinya Yamanka, a 2012 Nobel Prize winner in physiology from Japan.

Skolkovo Tech Research Center officials Anton Burns and Victor Kotelyansky will also be presenting at the conference on the topics of cancer research, RNA therapy and biomedicine.

During the conference, scientists from across Russia, the U.S. and Europe will discuss the future of biomedicine and share their research data among other specialists.

Conference organizers expect discussion topics to center on multifunctional stem cells, stem cell therapy, RNA therapy and regenerative medicines.

The Skolkovo Fund, which is owned in part by Uzbek mogul Iskander Makhmudov, was introduced in 2009 by former Russian President Dmitry Medvedev.